View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.
Parviz A. Shamlou, PhD (Executive Director & Head, Jefferson Institute for Bioprocessing)
Date: Wednesday, May 1
Time: 11:45am - 12:30pm
Track: Bio-Processing Symposium
Vault Recording: TBD
Rapid advances in life sciences combined with globalization of biomanufacturing achieved through unprecedented growth in advance technologies are leading to new and increasingly sophisticated therapeutic modalities that promise significant economic growth and prosperity for nations and companies that invest in them. These therapies include next generation monoclonal antibodies, fusion proteins, antibody drug conjugates, CAR-T cell and gene therapies, to name but a few. Provision of skilled workforce with relevant training is absolutely critical to the commercial success of these therapies and the growth of the global biomanufacturing.
This presentation and the follow up discussion is built on the premise that the global biomanufacturing continues to experience a real shortage of skilled workforce and that industry-academic partnerships and initiatives such as NIMBL, NIBRT and the Jefferson Institute for Bioprocessing (JIB) are working collaboratively to define the needs of industry and developing strategies to solve the skills workforce gap by attracting, training and retaining talent. Specifically, these partnerships are addressing the essential skill sets required by the biomanufacturing industries while simultaneously prioritize and providing the underpinning science and engineering training requirements through true collaboration.
Please join the discussion and participate to learn how best to exploit these partnerships to help your company achieve its potential.